BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• 

  Rare disease

  UniQure Eyes Phase 3 for Huntington’s Gene Therapy Despite Makary’s Apparent Criticism

  Days after FDA Commissioner Marty Makary appeared to malign uniQure’s AMT-130 in an interview with CNBC, the agency confirmed to the biotech that a sham surgery–controlled study is needed before submitting the gene therapy for approval.

  March 2, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

  Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

  March 2, 2026

   · 

  1 min read
• 

  Layoffs

  BioAtla Axes 70% of Staff, Explores Strategic Options

  Less than a year after cutting roughly 30% of its employees, BioAtla is letting go of an even larger chunk of its workforce as it considers its future, which could include strategic partnerships and selling off assets.

  March 2, 2026

   · 

  1 min read

   · 

  Angela Gabriel
• Press Releases

  AI in Medical Writing Certification Program Launched by TrialAssure to Support Greater Adoption Across Pharma and Biotech

  March 2, 2026

   · 

  1 min read